Which hormone replacement therapy may reduce the risk of ovarian cancer? - Renew Medical HRT Clinic

Ovarian cancer is a disease in which malignant cells form in the tissues of the ovaries. It is the fifth leading cause of cancer death in women. Several factors can increase the risk of developing ovarian cancer, including family history, age, and use of hormone replacement therapy (HRT). Some forms of HRT may help reduce the risk of ovarian cancer. The key is the type of HRT used:

Specifically, research indicates that using estrogen along with progestin for at least 5 years can reduce ovarian cancer risk. Some key study findings: The protective effect appears strongest with longer-term consistent use. Exactly why progestins may lower risk is still being studied, but possible reasons include: More research is still needed, but the current evidence suggests progestin-combination HRT lasting at least 3-5 years may offer protective benefits against ovarian cancer. When considering HRT for ovarian cancer risk reduction, Balance and moderation are key principles: If you're approaching menopause or experiencing symptoms, have an open discussion with your doctor about your health history and options for relief - including specifics about HRT regimens that may reduce ovarian cancer risk. At Renew Medical HRT Clinic, we specialize in personalized hormone replacement therapies and balancing treatments tailored to your unique needs and health goals: Managing menopause symptoms while reducing health risks is possible. Contact Renew Medical HRT Clinic today to learn about science-based hormone therapy approaches that may help lower your chances of ovarian cancer. Our expertise and care can help guide you to better wellbeing during this transition.

Our Services

Get Free Consultation